An examination of 13 trials involving nearly 50,000 individuals found no significant difference in the incidence of cancer between those who received folic acid supplements for five years and those who took placebos. Folic acid was not associated with a greater likelihood of developing certain types of cancer, either, including cancers of the colon, prostate, lung or breast.
Folic acid supplementation doesn't boost cancer risk, analysis finds
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||